Structure of the human P2X3 receptor reveals the basis for subtype-selective inhibition by sivopixant

Roche MediaRoche and Nurix Therapeutics Announce Global Collaboration | PharmExec - Pharmaceutical Executive

Endpoints NewsIncyte CEO sees $2B Vega deal aiding a post-Jakafi future

Clinical OMICsCortical On/Off Switch Provides Sleep Benefits to Awake Mice

Clinical OMICsGLP-1 Drugs Linked to Lower Rates of Substance Use Disorders

Endpoints NewsCity Therapeutics gets $99M to gather data on three RNAi medicines

Clinical OMICsProPure™ Endotoxin-Free Proteins for Reliable Cancer Research

Clinical OMICsTARGA Imager Enables High-Resolution Imaging of Neurodevelopmental Models

BioPharma DiveRoche stakes $700M on Nurix’s protein-degrading drug

Clinical OMICsSignatera™ as a Pan-Cancer Decision-Making Tool to Illuminate the Care Pathway

Endpoints NewsGoHealth files for bankruptcy, as Medicare Advantage insurers pull back

AgilentHow Investors May Respond To Agilent Technologies (A) Expanding AI-Enabled Lab Solutions And Oncology Diagnostics - simplywall.st